Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

ClinicalTrials.gov ID: NCT03030599

Public ClinicalTrials.gov record NCT03030599. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of JZP-258.

Study identification

NCT ID
NCT03030599
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
201 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 14, 2017 (Actual)
Primary completion
Jan 24, 2019 (Actual)
Completion
Jul 10, 2019 (Actual)
Last update posted
Nov 12, 2020

2017 – 2019

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
SDS Clinical Trials, Inc. Orange California 92858 —
Stanford Health Services Stanford California 94305 —
Colorado Sleep Institute Boulder Colorado 80301 —
Pulmonary Disease Specialists Kissimmee Florida 34741 —
Fort Wayne Neurological Center Fort Wayne Indiana 46804 —
Kentucky Research Group Louisville Kentucky 40218 —
Center for Sleep & Wake Disorders Chevy Chase Maryland 20815 —
Montefiore/ Sleep-Wake Disorders Center The Bronx New York 10467 —
Gastonia Medical Specialty Clinic Gastonia North Carolina 94305 —
Research Carolina Huntersville North Carolina 28078 —
Intrepid Research Cincinnati Ohio 45245 —
Cleveland Clinic, Sleep Disorder Center Cleveland Ohio 44195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03030599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2020 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03030599 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →